drugset / Trial / NCT00276978

Aripiprazole Augmentation Therapy in Treatment-resistant Depression

NCT00276978

Phase 3 Withdrawn University Hospital Freiburg
NaSingle-groupOpen-labelTreatment

Summary

20 therapy-refractory patients with major depression will be treated for 3 weeks with Aripiprazole 10 mg/d. Effectivity will be assessed using a pre-post comparison of different psychopathological rating scales and patient adherence.

Timeline

Start
2005-06
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 10 mg